HIGHLIGHTS
- who: Hiroshi Kawabata from the Department of Hematology, National Hospital Organization Kyoto Medical Center, ‑, Fukakusa Mukaihata‑cho, Fushimi‑ku, Kyoto, ‑8555, Japan have published the research: Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study, in the Journal: (JOURNAL)
- what: A multicenter single-arm (2 groups) open-label phase III study was conducted to assess the efficacy and safety of ferric derisomaltose (FDI) when administered by intravenous (IV) bolus injection (n = 30) or drip infusion (n = 10) in Japanese patients with IDA associated with gastrointestinal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.